Nick Freemantle

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Arterial Hypertension

Systematic Review

Angiotensin Converting Enzyme

Top Venues

Diabetes, obesity & metabolism

European heart journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Jochen Seufert, Nick Freemantle, Cristian Guja, Martin Haluzík, Mathilde Tournay, Carine Vera, Mireille Bonnemaire, Janos T Kis
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use. Diabetes, obesity & metabolism 26 (7) (2024)
Jochen Seufert, Nick Freemantle, Cristian Guja, Martin Haluzík, Mathilde Tournay, Carine Vera, Mireille Bonnemaire, Janos T Kis
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use. Diabetes, obesity & metabolism (2024)
Mario F L Gaudino, Nick Freemantle, Rafael Sadaba
In memoriam: Professor Domenico Pagano. European heart journal 44 (5) (2023)
Mario F L Gaudino, Nick Freemantle, Rafael Sadaba
In memoriam: Professor Domenico Pagano. European heart journal 44 (5) (2023)
Jamie A Mawhinney, Craig A Mounsey, Alastair O'Brien, J Rafael Sádaba, Nick Freemantle
Reply to Mawhinney et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 64 (6) (2023)
Cristian Guja, János Tibor Kis, Martin Haluzík, Mireille Bonnemaire, Gregory Bigot, Mathilde Tournay, Nick Freemantle, Jochen Seufert
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well-tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data. Diabetes, obesity & metabolism (2023)
Adam Ioannou, Paolo Massa, Rishi K Patel, Yousuf Razvi, Aldostefano Porcari, Muhammad U Rauf, Anita Jiang, Giacomo Cabras, Stefano Filisetti, Roos E Bolhuis, Francesco Bandera, Lucia Venneri, Ana Martinez-Naharro, Steven Law, Tushar Kotecha, Ruta Virsinskaite, Daniel S Knight, Michele Emdin, Aviva Petrie, Helen Lachmann, Ashutosh Wechelakar, Mark Petrie, Alun D Hughes, Nick Freemantle, Philip N Hawkins, Carol Whelan, John Jv McMurray, Julian David Gillmore, Marianna Fontana
Conventional heart failure therapy in cardiac ATTR amyloidosis. European heart journal (2023)
Cristian Guja, János Tibor Kis, Martin Haluzík, Mireille Bonnemaire, Gregory Bigot, Mathilde Tournay, Nick Freemantle, Jochen Seufert
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real-world data. Diabetes, obesity & metabolism (2023)
Livio Garattini, Marco Badinella Martini, Nick Freemantle, Alessandro Nobili
Integrated care in a National Health Service: better horizontal than vertical for general practice? Family practice 39 (6) (2022)
Nick Freemantle, Yingxin Xu, Florence R Wilson, Patricia Guyot, Chieh-I Chen, Sam Keeping, Gerasimos Konidaris, Keith Chan, Andreas Kuznik, Kokuvi Atsou, Emily Glowienka, Jean-Francois Pouliot, Giuseppe Gullo, Petra Rietschel
Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50. Therapeutic advances in medical oncology 14 (2022)
Mario F L Gaudino, Nick Freemantle, Rafael Sadaba
In memoriam: Professor Domenico Pagano. European heart journal (2022)
David M Lowe, Li-An K Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, Amalia Ndoutoumou, Divya Shah, Alexander Lennon, Abhulya Rai, Akosua A Agyeman, Anna Checkley, Nicola Longley, Hakim-Moulay Dehbi, Nick Freemantle, Juanita Pang, Joseph F Standing, null null
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19. PLoS medicine 19 (10) (2022)
Larisa Duffy, Caroline S Clarke, Gemma Lewis, Louise Marston, Nick Freemantle, Simon Gilbody, Rachael Maree Hunter, Tony Kendrick, David S Kessler, Michael King, Paul Lanham, Dee Mangin, Michael V Moore, Irwin Nazareth, Nicola Wiles, Faye Bacon, Molly Bird, Sally Brabyn, Alison Burns, Yvonne Donkor, Anna Hunt, Jodi Pervin, Glyn Lewis
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. Health technology assessment (Winchester, England) 25 (69) (2022)
Domenico Pagano, Philip Home, Alar Irs, Jonathan A Ledermann, Giuseppe Curigliano, Tsuguo Iwatani, John Mandrola, Nick Freemantle
The path for medical associations to sponsor trustworthy guidelines: is it feasible? Journal of the Royal Society of Medicine 115 (7) (2022)
Nick Freemantle, Patrick O Myers, Matthias Siepe
Do all roads lead to Rome? Critical reassessment of the individual patient meta-analysis on bypass grafts by Gaudino et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 63 (1) (2022)
Livio Garattini, Michela Bozzetto, Guiseppe Remuzzi, Nick Freemantle, Alessandro Nobili
Primary care in a National Health Service: time for radical reform. Family practice 39 (5) (2022)
Nick Freemantle, Patrick O Myers, Matthias Siepe
Do all roads lead to Rome? Critical reassessment of the individual patient meta-analysis on bypass grafts by Gaudino et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 63 (1) (2022)
Norin Ahmed, Jessica K Bone, Gemma Lewis, Nick Freemantle, Catherine J Harmer, Larisa Duffy, Glyn Lewis
The effect of sertraline on emotional processing: secondary analyses of the PANDA randomised controlled trial. Psychological medicine (2021)
Lawrence Blonde, Timothy S Bailey, Sean D Sullivan, Nick Freemantle
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme. Diabetes, obesity & metabolism 23 (8) (2021)
Nick Freemantle, Didac Mauricio, Andrea Giaccari, Timothy Bailey, Ronan Roussel, Denise Franco, Baptiste Berthou, Valerie Pilorget, Jukka Westerbacka, Zsolt Bosnyak, Mireille Bonnemaire, Anna M G Cali, My-Liên Nguyên-Pascal, Alfred Penfornis, Manuel Perez-Maraver, Jochen Seufert, Sean D Sullivan, John Wilding, Carol Wysham, Melanie Davies
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. Current medical research and opinion 36 (4) (2020)
Laura J Shallcross, Patrick Rockenschaub, Ruth Marion Blackburn, Irwin Nazareth, Nick Freemantle, Andrew C Hayward
Antibiotic prescribing for lower UTI in elderly patients in primary care and risk of bloodstream infection: A cohort study using electronic health records in England. PLoS medicine 17 (9) (2020)
Nick Freemantle, Sophie Jourdan
Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes". Diabetes, obesity & metabolism 21 (7) (2019)
James Tosin Akinlua, Richard Meakin, Ibrahim Bashir, Nick Freemantle
Beliefs about hypertension among primary health care workers and clients in Nigeria: A qualitative study. PloS one 13 (12) (2018)
Yifeng Liu, Emma Pencheon, Rachael Maree Hunter, Joanna Moncrieff, Nick Freemantle
Recruitment and retention strategies in mental health trials - A systematic review. PloS one 13 (8) (2018)